GlassScriptPhysician profile
Patricia Klem
NPI 1164626545
$8,647.49
in general payments reported to CMS, 2019-2025
39 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,231 · 2020: $453 · 2021: $714 · 2022: $1,069 · 2023: $1,558 · 2024: $2,249 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,115 · Travel and Lodging: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,114.73 |
| Travel and Lodging | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,333.24 | 2019-2025 | |
| Janssen Biotech, INC. | $1,112.81 | 2019-2025 | Tremfya |
| Pfizer INC. | $969.43 | 2019-2025 | |
| Lilly USA, LLC | $554.26 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $490.87 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $490.73 | 2019-2025 | |
| Dermavant Sciences, INC. | $388.11 | 2023-2024 | Vtama |
| Ucb, INC. | $289.62 | 2020-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $284.21 | 2020-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $282.22 | 2021-2025 | Absorica Ld, Winlevi, Ilumya |
| Amgen INC. | $254.72 | 2022-2024 | Otezla |
| Leo Pharma INC. | $237.43 | 2019-2025 | Adbry, Anzupgo |
| Celgene Corporation | $196.03 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $179.95 | 2022-2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $177.45 | 2023-2025 | Zoryve |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Klem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.